Finance

Beta
Lists
HEMO:LON
Hemogenyx Pharmaceuticals PLC
GBX 790.00
+6.90%
(+51.00) 1D
Jun 26, 4:30:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for HEMO...
Open
GBX 804.00
High
GBX 804.00
Low
GBX 731.00
Mkt. cap
53.04M
Avg. vol.
16.82K
Volume
11.08K
52-wk high
GBX 1,800.00
52-wk low
GBX 124.00
EPS
-GBX 2.20
Shares outstanding
6.80M
No. of employees
16
Open
GBX 804.00
High
GBX 804.00
Low
GBX 731.00
Mkt. cap
53.04M
Avg. vol.
16.82K
Volume
11.08K
52-wk high
GBX 1,800.00
52-wk low
GBX 124.00
EPS
-GBX 2.20
Shares outstanding
6.80M
No. of employees
16
News stories
From sources across the web
About Hemogenyx Pharmaceuticals PLC
CEO-
Employees16
Founded2013
Headquarters-
SectorBiotechnology
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13M
1.13M
2.06M
2.06M
Operating expense
1.32M
1.32M
2.16M
2.16M
Total operating expenses
1.32M
1.32M
2.16M
2.16M
Operating income
-1.32M
-1.32M
-2.16M
-2.16M
Other non operating income
-
-
-1.15M
-1.15M
EBT including unusual items
-2.50M
-2.50M
-2.38M
-2.38M
EBT excluding unusual items
-2.50M
-2.50M
-2.24M
-2.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
33.28K
33.28K
-33.28K
-33.28K
Net income
-2.50M
-2.50M
-2.38M
-2.38M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
3.00
3.00
563.00
563.00
Interest expense
-59.94K
-59.94K
-54.83K
-54.83K
Net interest expenses
-59.94K
-59.94K
-54.27K
-54.27K
Depreciation and amortization charges
156.89K
156.89K
137.48K
137.48K
EBITDA
-1.27M
-1.27M
-2.13M
-2.13M
Gain or loss from assets sale
-
-
2.30K
2.30K
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of HEMO
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more